Anvisa Gives Green Light to SinoVac For Clinical Trials to Resume Medicine & Technology Nov 12, 2020 SinoVac is the third pharmaceutical company to halt and resume clinical trials after a volunteer suffered a severe adverse event.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts